Characterization of a Vaccine-Elicited Human Antibody with Sequence Homology to VRC01-Class Antibodies That Binds the C1C2 gp120 Domain

Scientists examined Env-specific B cell receptor sequences from participants in the HVTN 100 clinical trial, a Phase I/II clinical trial of an RV144-like vaccine regimen.